Day: March 25, 2026

Tonix Pharma is preparing to launch the first new therapy for fibromyalgia in the US in 16 years, after claiming FDA approval for Tonmya, an oral drug used to treat the pain associated with the condition. Tonmya – a new under-the-tongue formulation of well-established muscle relaxant cyclobenzaprine HCl – has been cleared to treat adults with fibromyalgia, a common condition causing chronic pain, fatigue, poor sleep, and cognitive dysfunction that is estimated to affect more than 10 million people in the US. It mostly affects women. Tonix is planning to launch…

Read More

  Nia McGregor A selfie of Nia, she has a white blonde bob and dark rimmed glasses. Shelving can be seen behind her with a TV screen on the right. Nia McGregor Nia used to enjoy travelling and riding her motorbike, but now every movement causes severe pain throughout her body For 48-year-old Nia McGregor, talking to people and even wearing clothes hurts. She has fibromyalgia, a condition that causes extreme physical pain and tiredness, and said at her lowest she was taking 79 different tablets a day. Ms McGregor,…

Read More

  Chronic back pain amplifies sound unpleasantness; fMRI links it to sensory circuits, and pain reprocessing therapy may help normalize responses.   Advertisement   Those with chronic back pain (CBP) are more sensitive to sound, with early evidence that pain reprocessing therapy could help reduce this heightened response, according to a study published in Annals of Neurology in February 2026.   CBP affects more than 600 million people worldwide and, in many cases, doesn’t have a clear physical cause, causing curiosities amongst researchers toward changes in how the brain processes…

Read More

  Chronic Pain Fibromyalgia, Pain, and Substance Use Disorders Fibromyalgia is a risk factor for opioid, cannabis, and alcohol use disorders.   Fibromyalgia affects between 4 and 10 million and 60 million people suffer from > 3months of pain   Fibromyalgia and chronic pain create a “fertile breeding ground” for self-medication and iatrogenic addiction. . Fibromyalgia involves abnormal pain processing; the brain struggles to turn off pain signals. Many brain pathways involved in fibromyalgia are also involved in addiction.   Addiction occurs through a cycle of central sensitization, inadequate relief,…

Read More

    Fibromyalgia is a complex chronic condition marked by widespread musculoskeletal pain, fatigue, and cognitive difficulties. Although its underlying mechanisms remain incompletely understood, psychological stress and lifestyle factors are thought to play a key role in symptom development and severity. Academic environments, often characterised by high workloads and sustained stress, may therefore represent a setting where fibromyalgia symptoms are particularly prevalent.   A new cross-sectional study conducted at Umm Al Qura University in Saudi Arabia offers insight into the burden of fibromyalgia symptoms among students and faculty, while also…

Read More